Delisting risk
SNOA · NASDAQ · Drug Manufacturers - Specialty & Generic

Sonoma Pharmaceuticals

Develops and manufactures shelf-stable hypochlorous-acid products for wound, skin, eye, foot, animal, and surface care.

$1.31
After-hours close−0.01 (−0.76%)
At close$1.32(−0.75%)
DateEstimateReportedSurprise
Nov 2026−$0.10
Aug 2026−$0.30$0.02+106.7%
Jun 2026−$0.24−$0.09+62.5%
Feb 2026−$0.29−$0.35−20.7%
Nov 2025−$0.31−$0.13+58.1%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
Jun 2025
Feb 2025
Nov 2024
Aug 2024
Jun 2024
Feb 2024
Nov 2023
Aug 2023
Jun 2023
Feb 2023
Nov 2022
Aug 2022
Jul 2022
Feb 2022
Nov 2021
Aug 2021
Jul 2021
Feb 2021
Nov 2020
Aug 2020
Jul 2020
Feb 2020
Nov 2019
Aug 2019
Jul 2019
Feb 2019
Nov 2018
Aug 2018
Jun 2018
Feb 2018
Nov 2017
Aug 2017
Jun 2017
Feb 2017
Nov 2016
Jul 2016
Jun 2016
Feb 2016
Nov 2015
Jul 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 16, 2026−$0.10$5.3M
Aug 6, 2026−$0.30$0.02+106.7%$5.0M$6.4M+28.4%
Jun 16, 2026−$0.24−$0.09+62.5%$5.6M$5.6M−0.1%
Feb 10, 2026−$0.29−$0.35−20.7%$5.5M$4.3M−20.6%
Nov 4, 2025−$0.31−$0.13+58.1%$4.3M$5.6M+31.5%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 7, 2025
Jun 17, 2025
Feb 5, 2025
Nov 7, 2024
Aug 8, 2024
Jun 17, 2024
Feb 8, 2024
Nov 13, 2023
Aug 10, 2023
Jun 21, 2023
Feb 14, 2023
Nov 14, 2022
Aug 11, 2022
Jul 13, 2022
Feb 11, 2022
Nov 15, 2021
Aug 16, 2021
Jul 14, 2021
Feb 16, 2021
Nov 20, 2020
Aug 14, 2020
Jul 10, 2020
Feb 14, 2020
Nov 14, 2019
Aug 13, 2019
Jul 8, 2019
Feb 14, 2019
Nov 8, 2018
Aug 8, 2018
Jun 13, 2018
Feb 7, 2018
Nov 9, 2017
Aug 8, 2017
Jun 5, 2017
Feb 9, 2017
Nov 10, 2016
Jul 28, 2016
Jun 16, 2016
Feb 4, 2016
Nov 5, 2015
Jul 30, 2015